Immobilized B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-B7-H3 Antibody, hFc Tag with the EC50 of 65.6 ng/ml determined by ELISA.

The purity of B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human) is greater than 95% as determined by SEC-HPLC.

B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human

B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.

产品编号	Z03891
规格	100 μg 500 μg 大单询价
数量
价格	￥9900


联系我们

产品简介

Species

Human

Protein Construction

B7-H3 (4Ig) /B7-H3b (Gly27-Thr461) Accession # Q5ZPR3-1	hFc
N-term	C-term

Conjugate

FITC

Purity

> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC

Endotoxin Level

Less than 1EU per μg by the LAL method.

Biological Activity

Immobilized B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human (Cat.No.: Z03891) at 1 μg/ml (100μl/Well) on the plate can bind Biotinylated Anti-B7-H3 Antibody, hFc Tag

Expression System

HEK293

Theoretical Molecular Weight

73.4 kDa

Apparent Molecular Weight

Due to glycosylation, the protein migrates to 90-110 kDa based on Bis-Tris PAGE result.

Formulation

Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4.

Reconstitution

It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O more than 100 μg/ml.

Storage & Stability

Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

图例

The purity of B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human) is greater than 95% as determined by SEC-HPLC.

B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

技术背景

Target Background	B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.
Synonyms	B7-H3; CD276; PSEC0249; 4Ig-B7-H3; UNQ309; PRO352; B7 homolog 3; CD276

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.